FTC and FDA Take Action Against Unproven Diabetes Treatments

Home » FTC and FDA Take Action Against Unproven Diabetes Treatments

On September 9, 2021, the Federal Trade Commission (“FTC”) announced they teamed up with the U.S. Food and Drug Administration (“FDA”) to address concerns regarding companies advertising unproven treatments or cures for diabetes. The FTC issued cease-and-desist letters to 10 companies, including Ar-Rahmah Pharm, Aceva, and others, directing them to halt their claims within 15 […]

Subscribe today to access the resources to help you stay compliant

CLIClaw Subscription

Save $89/year

$499

Yearly

Standard

$49

Monthly

Unlock Your Compliance Solutions Now

Here you will find access to a collection of educational resources, customizable policies and practical solutions for your journey to knowledge empowerment. These proven materials used to design compliance programs for some of the largest marketers including online education, simplified guides, and checklists, as well as public resources, programs and outlines which are designed to assist you in creating your community of compliance.

Continuous updates and additional resources will keep you ahead in compliance.